Hematology/Oncology

Topp BG, Channavazzala M, Mayawala K, De Alwis DP, Rubin E, Snyder A, Wolchok JD, Ribas A. Tumor dynamics in patients with solid tumors treated[...]

By sjmartinez • September 13, 2023

Russo RIC, Béguelin W, Flaqué MCD, Proietti CJ, Venturutti L, Galigniana N, Tkach M, Guzmán P, Roa JC, O'Brien NA, Charreau EH, Schillaci R, Elizalde[...]

By sjmartinez • September 10, 2023

Rentscher KE, Klopack ET, Crimmins EM, Seeman TE, Cole SW, Carroll JE. Social relationships and epigenetic aging in older adulthood: Results from the Health and[...]

By sjmartinez • September 10, 2023

Kulkarni AV, Tevethia H, Kumar K, Premkumar M, Muttaiah MD, Hiraoka A, Hatanaka T, Tada T, Kumada T, Kakizaki S, Vogel A, Finn RS, Rao[...]

By sjmartinez • September 8, 2023

Murthy V, Gafita A, Thin P, Nguyen K, Grogan T, Shen J, Drakaki A, Rettig M, Czernin J, Calais J. Prognostic Value of End-of-Treatment PSMA[...]

By sjmartinez • September 8, 2023

André F, Su F, Solovieff N, Hortobagyi G, Chia S, Neven P, Bardia A, D Tripathy, Lu YS, Lteif A, Taran T, Babbar N, Slamon[...]

By sjmartinez • September 7, 2023

Duong A, Roberts L, Cramm H, Evans MB, Mayhew E, Latimer-Cheung AE, Aiken A, Shirazipour CH. I AM FAMILY: Understanding the adapted sport experiences of[...]

By sjmartinez • September 5, 2023

Last week, I shared an overview of our department’s achievements in securing new federal grant funding during FY 22-23 to support a broad range of[...]

By sjmartinez • September 5, 2023

Selim O, Song C, Kumar A, Phelan R, Singh A, Federman N. A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma. Front[...]

By sjmartinez • September 4, 2023

Roschewski M, Patel MR, Reagan PM, Saba NS, Collins GP, Arkenau HT, de Vos S, Nuttall B, Acar M, Burke K, White RD, Udriste M,[...]

By sjmartinez • September 4, 2023